180 related articles for article (PubMed ID: 33009038)
1. Confluent White Matter in Progression to Alzheimer Dementia.
Heng LC; Lim SH; Foo H; Kandiah N
Alzheimer Dis Assoc Disord; 2021 Jan-Mar 01; 35(1):8-13. PubMed ID: 33009038
[TBL] [Abstract][Full Text] [Related]
2. Differential Effects of Confluent and Nonconfluent White Matter Hyperintensities on Functional Connectivity in Mild Cognitive Impairment.
Kumar D; Vipin A; Wong B; Ng KP; Kandiah N
Brain Connect; 2020 Dec; 10(10):547-554. PubMed ID: 33050714
[No Abstract] [Full Text] [Related]
3. Association of White Matter Hyperintensity Progression with Cognitive Decline in Patients with Amnestic Mild Cognitive Impairment.
Hirao K; Yamashita F; Tsugawa A; Haime R; Fukasawa R; Sato T; Kanetaka H; Umahara T; Sakurai H; Hanyu H; Shimizu S
J Alzheimers Dis; 2021; 80(2):877-883. PubMed ID: 33579856
[TBL] [Abstract][Full Text] [Related]
4. Prestroke statins, progression of white matter hyperintensities, and cognitive decline in stroke patients with confluent white matter hyperintensities.
Xiong Y; Wong A; Cavalieri M; Schmidt R; Chu WW; Liu X; Wong KS; Mok V
Neurotherapeutics; 2014 Jul; 11(3):606-11. PubMed ID: 24692001
[TBL] [Abstract][Full Text] [Related]
5. The burden of white matter hyperintensities is a predictor of progressive mild cognitive impairment in patients with Parkinson's disease.
Sunwoo MK; Jeon S; Ham JH; Hong JY; Lee JE; Lee JM; Sohn YH; Lee PH
Eur J Neurol; 2014 Jun; 21(6):922-e50. PubMed ID: 24661277
[TBL] [Abstract][Full Text] [Related]
6. White matter disease independently predicts progression from mild cognitive impairment to Alzheimer's disease in a clinic cohort.
Prasad K; Wiryasaputra L; Ng A; Kandiah N
Dement Geriatr Cogn Disord; 2011; 31(6):431-4. PubMed ID: 21757908
[TBL] [Abstract][Full Text] [Related]
7. White Matter Hyperintensities in Mild Cognitive Impairment and Lower Risk of Cognitive Decline.
Nolze-Charron G; Mouiha A; Duchesne S; Bocti C;
J Alzheimers Dis; 2015; 46(4):855-62. PubMed ID: 26402625
[TBL] [Abstract][Full Text] [Related]
8. White matter hyperintensities are not associated with cognitive decline in early Parkinson's disease - The DeNoPa cohort.
Hanning U; Teuber A; Lang E; Trenkwalder C; Mollenhauer B; Minnerup H
Parkinsonism Relat Disord; 2019 Dec; 69():61-67. PubMed ID: 31678722
[TBL] [Abstract][Full Text] [Related]
9. Periventricular white matter hyperintensities and the risk of dementia: a CREDOS study.
Kim S; Choi SH; Lee YM; Kim MJ; Kim YD; Kim JY; Park JH; Myung W; Na HR; Han HJ; Shim YS; Kim JH; Yoon SJ; Kim SY; Kim DK
Int Psychogeriatr; 2015 Dec; 27(12):2069-77. PubMed ID: 26212042
[TBL] [Abstract][Full Text] [Related]
10. Association between white matter hyperintensity and medial temporal atrophy at various stages of Alzheimer's disease.
Kandiah N; Chander RJ; Ng A; Wen MC; Cenina AR; Assam PN
Eur J Neurol; 2015 Jan; 22(1):150-5. PubMed ID: 25142829
[TBL] [Abstract][Full Text] [Related]
11. The Associations Between Serum Insulin-like Growth Factor-I, Brain White Matter Volumes, and Cognition in Mild Cognitive Impairment and Alzheimer's Disease.
Horvath A; Quinlan P; Eckerström C; Åberg ND; Wallin A; Svensson J
J Alzheimers Dis; 2024; 99(2):609-622. PubMed ID: 38701139
[TBL] [Abstract][Full Text] [Related]
12. Magnetic resonance imaging white matter hyperintensities and brain volume in the prediction of mild cognitive impairment and dementia.
Smith EE; Egorova S; Blacker D; Killiany RJ; Muzikansky A; Dickerson BC; Tanzi RE; Albert MS; Greenberg SM; Guttmann CR
Arch Neurol; 2008 Jan; 65(1):94-100. PubMed ID: 18195145
[TBL] [Abstract][Full Text] [Related]
13. Heterogeneity of White Matter Hyperintensities in Cognitively Impaired Patients With Cerebral Small Vessel Disease.
Wang T; Jin A; Fu Y; Zhang Z; Li S; Wang D; Wang Y
Front Immunol; 2021; 12():803504. PubMed ID: 34956241
[TBL] [Abstract][Full Text] [Related]
14. Sex differences in the development of mild cognitive impairment and probable Alzheimer's disease as predicted by hippocampal volume or white matter hyperintensities.
Burke SL; Hu T; Fava NM; Li T; Rodriguez MJ; Schuldiner KL; Burgess A; Laird A
J Women Aging; 2019; 31(2):140-164. PubMed ID: 29319430
[TBL] [Abstract][Full Text] [Related]
15. Cognitive Impact of Cerebral Small Vessel Disease Changes in Patients With Hypertension.
Jiménez-Balado J; Riba-Llena I; Abril O; Garde E; Penalba A; Ostos E; Maisterra O; Montaner J; Noviembre M; Mundet X; Ventura O; Pizarro J; Delgado P
Hypertension; 2019 Feb; 73(2):342-349. PubMed ID: 30606062
[TBL] [Abstract][Full Text] [Related]
16. APOE4 and Confluent White Matter Hyperintensities Have a Synergistic Effect on Episodic Memory Impairment in Prodromal Dementia.
Kumar D; Yatawara C; Wang B; Wong B; Tan YJ; Zailan FZ; Ng KP; Kandiah N
J Alzheimers Dis; 2022; 87(3):1103-1114. PubMed ID: 35431245
[TBL] [Abstract][Full Text] [Related]
17. Association of Brain Magnetic Resonance Imaging Signs With Cognitive Outcomes in Persons With Nonimpaired Cognition and Mild Cognitive Impairment.
Wu A; Sharrett AR; Gottesman RF; Power MC; Mosley TH; Jack CR; Knopman DS; Windham BG; Gross AL; Coresh J
JAMA Netw Open; 2019 May; 2(5):e193359. PubMed ID: 31074810
[TBL] [Abstract][Full Text] [Related]
18. White matter hyperintensity distribution differences in aging and neurodegenerative disease cohorts.
Dadar M; Mahmoud S; Zhernovaia M; Camicioli R; Maranzano J; Duchesne S;
Neuroimage Clin; 2022; 36():103204. PubMed ID: 36155321
[TBL] [Abstract][Full Text] [Related]
19. Amnestic multiple cognitive domains impairment and periventricular white matter hyperintensities are independently predictive factors progression to dementia in mild cognitive impairment.
Lee HK; Lee YM; Park JM; Lee BD; Moon ES; Chung YI
Int J Geriatr Psychiatry; 2014 May; 29(5):526-32. PubMed ID: 24123391
[TBL] [Abstract][Full Text] [Related]
20. Automated White Matter Hyperintensity Segmentation Using Bayesian Model Selection: Assessment and Correlations with Cognitive Change.
Fiford CM; Sudre CH; Pemberton H; Walsh P; Manning E; Malone IB; Nicholas J; Bouvy WH; Carmichael OT; Biessels GJ; Cardoso MJ; Barnes J;
Neuroinformatics; 2020 Jun; 18(3):429-449. PubMed ID: 32062817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
